We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAV
2101
DELISTED
Advantage Oil & Gas Ltd
AAV
| $187K | ﹤0.01% |
43,600
-4,200
| -9% | -$21.1K |
|
|
MXWL
2102
DELISTED
Maxwell Technologies Inc
MXWL
| $174K | ﹤0.01% |
30,176
+1,600
| +6% | +$8.32K |
|
2103
Ceragon Networks
CRNT
$194M
| $171K | ﹤0.01% |
86,300
+52,500
| +155% | +$103K |
|
2104
QuinStreet
QNST
$870M
| $168K | ﹤0.01% |
+20,060
| New | +$170K |
|
2105
Kearny Financial
KRNY
$592M
| $166K | ﹤0.01% |
+11,480
| New | +$171K |
|
|
DNR
2106
DELISTED
Denbury Resources, Inc.
DNR
| $163K | ﹤0.01% |
+73,774
| New | +$116K |
|
|
ISEE
2107
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $162K | ﹤0.01% |
51,966
+5,976
| +13% | +$16.8K |
|
|
WAIR
2108
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $161K | ﹤0.01% |
+21,709
| New | +$180K |
|
|
CGI
2109
DELISTED
Celadon Group Inc
CGI
| $159K | ﹤0.01% |
24,800
-3,823
| -13% | -$25.2K |
|
2110
PhenixFIN
PFX
| $158K | ﹤0.01% |
1,514
+385
| +34% | +$43.9K |
|
|
PES
2111
DELISTED
Pioneer Energy Services Corp.
PES
| $157K | ﹤0.01% |
51,487
-60,200
| -54% | -$132K |
|
|
CLD
2112
DELISTED
Cloud Peak Energy Inc
CLD
| $157K | ﹤0.01% |
+35,232
| New | +$148K |
|
|
BHR
2113
Braemar Hotels & Resorts
BHR
$153M
| $154K | ﹤0.01% |
15,999
-464
| -3% | -$4.43K |
|
2114
Clear Channel Outdoor Holdings
CCO
$1.23B
| $153K | ﹤0.01% |
33,300
-18,300
| -35% | -$78.5K |
|
|
PLYA
2115
DELISTED
Playa Hotels & Resorts
PLYA
| $151K | ﹤0.01% |
14,000
-28,100
| -67% | -$299K |
|
2116
Archrock
AROC
$6.33B
| $150K | ﹤0.01% |
14,323
-93,710
| -87% | -$1.02M |
|
2117
KVH Industries
KVHI
$177M
| $149K | ﹤0.01% |
14,400
-100
| -0.7% | -$1.11K |
|
|
MVC
2118
DELISTED
MVC Capital, Inc.
MVC
| $148K | ﹤0.01% |
14,052
| – | – |
|
|
SDRL
2119
DELISTED
Seadrill Limited Common Stock
SDRL
| $144K | ﹤0.01% |
2,332
-999
| -30% | -$79.6K |
|
|
EXK
2120
Endeavour Silver
EXK
$2.32B
| $143K | ﹤0.01% |
59,700
-17,100
| -22% | -$38.6K |
|
2121
Cartesian Therapeutics
RNAC
$232M
| $143K | ﹤0.01% |
+487
| New | +$213K |
|
|
HDSN
2122
Hudson Technologies
HDSN
$267M
| $136K | ﹤0.01% |
+22,400
| New | +$136K |
|
2123
Data I/O
DAIO
$32M
| $135K | ﹤0.01% |
+11,200
| New | +$133K |
|
2124
TETRA Technologies
TTI
$1.23B
| $134K | ﹤0.01% |
+31,320
| New | +$108K |
|
|
CBAY
2125
DELISTED
Cymabay Therapeutics
CBAY
| $134K | ﹤0.01% |
14,600
+800
| +6% | +$6.84K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.